Breaking News Instant updates and real-time market news.

FLOW

SPX FLOW

$36.30

0.52 (1.45%)

, LPX

Louisiana-Pacific

$26.70

-0.36 (-1.33%)

04:55
09/14/17
09/14
04:55
09/14/17
04:55

RBC Capital to hold a conference

2017 Global Industrials Conference is being held in Las Vegas on September 13-14.

FLOW

SPX FLOW

$36.30

0.52 (1.45%)

LPX

Louisiana-Pacific

$26.70

-0.36 (-1.33%)

MAS

Masco

$37.51

-0.6 (-1.57%)

URI

United Rentals

$128.82

1.13 (0.88%)

AXL

American Axle

$15.73

0.33 (2.14%)

OSK

Oshkosh

$75.50

-0.72 (-0.94%)

WLK

Westlake Chemical

$79.29

-0.13 (-0.16%)

PNR

Pentair

$64.54

0.12 (0.19%)

DHI

D.R. Horton

$37.16

-0.58 (-1.54%)

OSB

Norbord

$37.62

-0.77 (-2.01%)

VMC

Vulcan Materials

$117.02

-0.98 (-0.83%)

CE

Celanese

$99.27

0.19 (0.19%)

TEN

Tenneco

$56.16

0.75 (1.35%)

GE

General Electric

$24.11

0.2 (0.84%)

NX

Quanex

$20.25

-0.45 (-2.17%)

EGL

Engility

$30.57

-0.03 (-0.10%)

ATKR

Atkore

$18.44

0.12 (0.66%)

CSRA

CSRA

$32.32

-0.24 (-0.74%)

SITE

SiteOne Landscape

$52.45

0.25 (0.48%)

HDS

HD Supply

$33.54

-0.21 (-0.62%)

ROP

Roper Technologies

$235.58

-1.79 (-0.75%)

GGG

Graco

$117.24

0.01 (0.01%)

  • 14

    Sep

  • 14

    Sep

  • 25

    Sep

  • 28

    Sep

  • 02

    Oct

  • 02

    Oct

  • 30

    Oct

  • 09

    Nov

FLOW SPX FLOW
$36.30

0.52 (1.45%)

08/03/17
STFL
08/03/17
NO CHANGE
STFL
SPX FLOW weakness unjustified, says Stifel
Stifel analyst Nathan Jones says that the 6.9% decline in SPX Flow's stock yesterday following its preannouncement was "un-explainable." The analyst recommends buying the shares on weakness.
07/11/17
WOLF
07/11/17
INITIATION
WOLF
Peer Perform
SPX FLOW initiated with a Peer Perform at Wolfe Research
08/08/17
SUSQ
08/08/17
UPGRADE
SUSQ
Positive
SPX FLOW upgraded to Positive from Neutral at Susquehanna
08/08/17
SUSQ
08/08/17
UPGRADE
Target $41
SUSQ
Positive
SPX FLOW upgraded to Positive at Susquehanna
As previously reported, Susquehanna analyst Robert Barry upgraded SPX FLOW to Positive from Neutral as he sees the recent pullback in the shares pushing the stock to an attractive entry point. He sees operational performance improving under new management, strong margins, and an acceleration of the top line. Barry lowered his price target to $41 from $42 on SPX FLOW shares.
LPX Louisiana-Pacific
$26.70

-0.36 (-1.33%)

04/12/17
04/12/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Sell from Hold at Rafferty Capital with analyst Richard Bove saying he does not expect bank stocks in general to do well for months and he thinks on Wells specifically that its Directors report indicates that the company is in the midst of a multi-year re-structuring process. Bove lowered his 12-month price target range for Wells Fargo shares to $46-$60 from $52-$68. 2. Tractor Supply (TSCO) was downgraded to Equal Weight from Overweight at Stephens and to Neutral from Overweight at JPMorgan. 3. Avinger (AVGR) downgraded to Perform from Outperform at Oppenheimer with analyst Steven Lichtman downgraded Avinger (AVGR) to Perform from Outperform after its Q1 sales came in below estimates on lower than expected Pantheris utilization and following the company's announcement that it plans to reduce its workforce by 33%, while pursuing strategic alternatives, including a capital raise from strategic investors, OUS partnerships, or a merger/sale. 4. Louisiana-Pacific (LPX) downgraded to Neutral from Buy at Buckingham with the firm citing recent share strength that has made risk/reward more balanced. 5. LVMH (LVMUY) downgraded to Hold from Buy at Societe Generale with analyst Thierry Cota citing a lack of upside following the stock's recent rally. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/08/17
05/08/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Goldman Sachs analyst Mark Delaney downgraded Micron (MU) Technology to Neutral from Buy and lowered his price target for the shares to $30 from $32. With consensus estimates up 70% for the current fiscal year on better memory prices and margins, the major catalyst for shares has already played out, Delaney tells investors. 2. Bank of America Merrill Lynch analyst Steve Byrne downgraded LyondellBasell (LYB) two notches to Underperform from Buy and lowered its price target to $80 from $100, telling investors supply growth is set to impact margins. The analyst said polyethylene industry is over-earning and capacity has accelerated and will result in global polyethylene supply growth that is expected to exceed demand through 2018. 3. Goldman Sachs analyst Toshiya Hari removed Lam Research (LRCX) from the Conviction Buy List given recent outperformance. The analyst maintains a Buy rating and increased his price target to $160 from $153, citing strong industry fundamentals and market share gains, among other reasons. 4. Deutsche Bank analyst Jonathan Arnold downgraded Consolidated Edison (ED) to Sell saying the valuation is "stretched" at current share levels. The analyst sees 7% downside to his unchanged price target of $74. 5. DA Davidson analyst Steven Chercover downgraded Louisiana-Pacific (LPX) to Neutral citing valuation following the company's Q1 results, as he believes "much of the good news on commodities" is already priced into the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/08/17
DADA
05/08/17
DOWNGRADE
Target $27
DADA
Neutral
Louisiana-Pacific downgraded to Neutral from Buy at DA Davidson
DA Davidson analyst Steven Chercover downgraded Louisiana-Pacific to Neutral citing valuation following the company's Q1 results. The analyst believes "much of the good news on commodities" is already priced into the shares. He has a $27 price target for the stock.
04/12/17
BUCK
04/12/17
DOWNGRADE
Target $27
BUCK
Neutral
Louisiana-Pacific downgraded to Neutral on valuation at Buckingham
Buckingham downgraded Louisiana-Pacific to Neutral from Buy and raised its price target to $27 from $26 citing recent share strength that has made risk/reward more balanced.
MAS Masco
$37.51

-0.6 (-1.57%)

05/17/17
WELS
05/17/17
NO CHANGE
WELS
Masco can meet new EPS target, says Wells Fargo
After attending Masco's Analyst Day, Wells Fargo says that the company's 2019 EPS target of $2.50 is "distinctly doable." The firm thinks that the company has several upcoming positive catalysts, and it raised its estimates for the company while keeping an Outperform rating on the shares.
04/06/17
04/06/17
NO CHANGE

Masco upgraded on accelerating sales, lower discounts at Longbow
As noted earlier, Longbow upgraded Masco to Buy from Neutral. Analyst Garik Shmois says that the sector's volume growth reached 7%-9% last quarter, up from 5%-7% in Q1. The analyst adds that discounts at home centers have dropped from year-ago levels. The analyst believes that the EPS of the company's core business can peak at as high as $5.19 this cycle, depending on the performance of the housing sector. Target $42.
06/22/17
FBCO
06/22/17
INITIATION
Target $36
FBCO
Neutral
Masco initiated with a Neutral at Credit Suisse
Credit Suisse analyst Susan Maklari initiated Masco with a Neutral and a $36 price target saying expected earnings growth and free cash flow are reflected in valuation.
04/11/17
NOMU
04/11/17
INITIATION
Target $39
NOMU
Buy
Masco initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Michael Wood started Masco with a Buy rating and $39 price target.
URI United Rentals
$128.82

1.13 (0.88%)

08/18/17
STFL
08/18/17
UPGRADE
STFL
Buy
United Rentals upgraded to Buy from Hold at Stifel
09/05/17
JEFF
09/05/17
NO CHANGE
Target $150
JEFF
Buy
Hurricane Harvey to boost growth at United Rentals, says Jefferies
Jefferies analyst Justin Jordan believes United Rentals may see $60M of immediate disaster recovery revenue from Hurricane Harvey, which equates to 1% of sales and EBITDA in 2017. The estimate does not include rebuild rental work and the possibility of Harvey being a positive catalyst for increased U.S. infrastructure spending, Jordan tells investors in a research note. The analyst keeps a Buy rating on the shares.
08/18/17
STFL
08/18/17
UPGRADE
STFL
Buy
United Rentals upgraded after acquisition at Stifel
As noted earlier, Stifel upgraded United Rentals to Buy from Hold. Analyst Stanley S. Elliott says that the company's acquisition of Neff increases his confidence in its outlook and leaves it better positioned to exploit favorable demand trends. He thinks that the additional scale and Untied Rentals' improving operations leave it well-positioned to outperform and increase its profits next year. Target $133.
08/18/17
08/18/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. United Rentals (URI) upgraded to Buy from Hold at Stifel with analyst Stanley Elliott saying that the company's acquisition of Neff (NEFF) increases his confidence in its outlook and leaves it better positioned to exploit favorable demand trends. 2. Tonix Pharmaceuticals (TNXP) upgraded to Buy from Neutral at Roth Capital with analyst Scott Henry believes Tonix's current valuation does not reflect the potential of the Tonmya program to treat PTSD and said the company has the cash runway to reach pivotal data readout in both first half 2018 and second half 2018. 3. Quanta Services (PWR) and MasTec (MTZ) were upgraded to Buy from Neutral at Citi. 4. Howard Bancorp (HBMD) upgraded to Overweight from Equal Weight at Stephens with analyst Austin Nicholas saying the in-market acquisition of 1st Mariner strategically deploys Howard's excess capital, creating the #1 community bank in Baltimore. 5. Myriad Genetics (MYGN) upgraded to Hold from Sell at Deutsche Bank with analyst Dan Leonard saying the risk/reward is now balanced following the company's weaker than expected FY18 outlook. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AXL American Axle
$15.73

0.33 (2.14%)

05/08/17
JPMS
05/08/17
INITIATION
Target $23
JPMS
Overweight
American Axle reinstated with an Overweight at JPMorgan
JPMorgan analyst Ryan Brinkman reinstated American Axle with an Overweight rating and $23 price target. The acquisition of Metaldyne Performance Group helps remove many of the historical reasons for company's low valuation, the analyst contends.
06/08/17
MSCO
06/08/17
NO CHANGE
MSCO
Morgan Stanley makes "big" cuts to US Auto Sales forecasts
Morgan Stanley analyst Adam Jonas made "big" cuts to his US auto industry sales forecast, reducing his 2017 US SAAR forecast to 17.3M units from 18.3M units, 2018 to 16.4M units from 18.9M units, 2019 to 15M units from 19.2M units, and 2020 to 15M units from 18.7M units. Jonas believes the auto cycle may be hitting a point of diminishing returns following 8 years into the biggest cycle on record as used car values erode, pressuring conditions for selling new vehicles, and said new vehicle inventory levels continue to rise. Additionally, the analyst expects electrical margins to face increasing competition from new entrants and higher development costs. As a result, Jonas cut estimates across the board and downgraded Lear (LEA) to Underweight from Equal Weight.
06/21/17
GUGG
06/21/17
INITIATION
Target $18
GUGG
Buy
American Axle initiated with a Buy at Guggenheim
Guggenheim analyst Emmanuel Rosner started American Axle with a Buy rating and $18 price target.
06/22/17
DBAB
06/22/17
DOWNGRADE
DBAB
Hold
Dana Holding downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Rod Lache downgraded Dana Holding (DAN) to Hold from Buy, noting that the stock has risen to within 5% of the firm's target. Looking at the broader space, he contends that the backdrop remains unfavorable for Auto/Auto Parts stocks, though select suppliers can outperform if SAAR moderates slowly. Lache maintains Buy ratings on BorgWarner (BWA), Delphi (DLPH), and American Axle (AXL), which he views as having favorable near-term set-ups.
OSK Oshkosh
$75.50

-0.72 (-0.94%)

08/03/17
BOFA
08/03/17
UPGRADE
Target $78
BOFA
Neutral
Oshkosh upgraded to Neutral from Underperform at BofA/Merrill
BofA/Merrill analyst Ross Gilardi upgraded Oshkosh to Neutral and raised its price target to $78 from $60 citing better than expected Q3 results. The analyst had expected a slowdown in FY18 Defense earnings, that would lead to reduced earnings estimates, but Q3 results were much better than he expected. Gilardi raised his forecasts materially and said he was "taking a mulligan" on his previous thesis.
08/03/17
08/03/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comcast (CMCSA) upgraded to Buy from Neutral at Guggenheim with analyst Michael Morris citing an attractive valuation, a combination of solid trends at Cable Communications and NBCU content momentum, and strong balance sheet. 2. Caterpillar (CAT) upgraded to Neutral from Underweight at Atlantic Equities. 3. SodaStream (SODA) upgraded to Positive from Neutral at Susquehanna. 4. Walker & Dunlop (WD) upgraded to Outperform from Market Perform at JMP Securities with analyst Steven DeLaney saying investors may be overly focusing on quarterly results and the reduction in the company's gain on sale margin guidance for the second half of the year. 5. Oshkosh (OSK) upgraded to Neutral from Underperform at BofA/Merrill with analyst Ross Gilardi citing better than expected third quarter results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/27/17
RHCO
04/27/17
NO CHANGE
RHCO
Oshkosh should be bought on weakness, says SunTrust
SunTrust analyst Charles Brady says that the decline in Oshkosh's stock following its Q2 results was overdone. The analyst thinks that the company's defense business performed very well, while its access business beat expectations. He recommends buying the stock on weakness
08/23/17
STFL
08/23/17
NO CHANGE
STFL
Oshkosh outlook encouraging, says Stifel
After meeting with Oshkosh's management, Stifel analyst Stanley Elliott is "encouraged" by what he sees as the increased diversification of its business,and he says that its guidance for $1.7B of defense revenue for fiscal 2018 could be conservative. He thinks that it could sell its JLTV to foreign countries, and he calls the stock's valuation attractive. The analyst keeps an $80 price target and a Buy rating on the shares.
WLK Westlake Chemical
$79.29

-0.13 (-0.16%)

09/06/17
RHCO
09/06/17
NO CHANGE
RHCO
Westlake Chemical 2018, 2019 profits to beat expectations, says SunTrust
SunTrust analyst James Sheehan raised his estimates for Westlake, citing improving pricing trends. The analyst now expects Westlake's 2018 and 2019 profits to beat Street expectations. He raised his price target on the shares to $86 from $77 and keeps a Buy rating on the stock.
11/21/16
VERT
11/21/16
UPGRADE
Target $64
VERT
Buy
Westlake Chemical upgraded to Buy from Hold at Vertical Research
Vertical Research analyst Kevin McCarthy upgraded Westlake Chemical to Buy with a $64 price target saying the company best-in-class earnings upside in the event of US corporate tax reform and the Vinyls business will benefit from improved market conditions, deal synergies, and other cost cuts.
02/09/17
SBSH
02/09/17
INITIATION
Target $72
SBSH
Buy
Westlake Chemical initiated with a Buy at Citi
Citi analyst P.J. Juvekar started Westlake Chemical with a Buy rating and $72 price target. The company's acquisition of Axiall "was very timely" as the chlor alkali cycle is turning and could help offset a potential ethylene downturn in 2018, the analyst contends.
02/09/17
02/09/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ulta Beauty (ULTA) initiated with a Hold at Loop Capital. 2. Spark Therapeutics (ONCE) initiated with an Outperform at Leerink. 3. GTT Communications (GTT) initiated with a Buy at BTIG. 4. Westlake Chemical (WLK) initiated with a Buy at Citi. 5. Bio-Techne (TECH) initiated with a Buy at Citi. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
PNR Pentair
$64.54

0.12 (0.19%)

07/11/17
WOLF
07/11/17
INITIATION
WOLF
Peer Perform
Pentair initiated with a Peer Perform at Wolfe Research
06/01/17
06/01/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pentair (PNR) reinstated with a Sell at Goldman Sachs. 2. Global Payments (GPN) coverage resumed with a Buy at Stifel. 3. Caesars (CZR) initiated with an Outperform at Oppenheimer. 4. Resolute Energy (REN) initiated with a Buy at SunTrust. 5. Ziopharm (ZIOP) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/01/17
GSCO
06/01/17
INITIATION
Target $61
GSCO
Sell
Pentair reinstated with a Sell at Goldman Sachs
Goldman analyst Joe Ritchie reinstated Pentair with a Sell and a $61 price target saying valuation is "stretched." Ritchie expects growth to underperform peers and sees limited room for margin improvement.
05/30/17
COWN
05/30/17
NO CHANGE
Target $59
COWN
Underperform
Pentair break-up value below current price, says Cowen
Cowen analyst Joseph Giordano noted Pentair has underperformed over the past six months but it has performed better recently in part to reflect the possibility of a breakup and/or acquisition. The analyst said his sum-of-the-parts valuation is roughly 10% lower than its current price. Giordano reiterated his Underperform rating, though raised his price target to $59 from $50 on Pentair shares.
DHI D.R. Horton
$37.16

-0.58 (-1.54%)

06/30/17
06/30/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Cabot Oil & Gas (COG) upgraded to Buy from Neutral at BofA/Merrill with analyst Doug Leggate saying Cabot 's gross Marcellus takeaway capacity will increase to 3.7 bcf/d from 2bcf/d by end of 2018 and positioned to increase free cash flow to $2B from $872M per year for 25 years. 2. Becton Dickinson (BDX) upgraded to Strong Buy from Outperform at Raymond James with analyst Lawrence Keusch saying he believes it should be a core holding based an an above average outlook for 5%-6% organic growth and mid-teens earnings increases with further potential upside. 3. Walgreens Boots Alliance (WBA) upgraded to Buy from Hold at Needham. 4. ManTech (MANT) upgraded to Buy from Hold at Loop Capital with analyst Joseph Vafi saying he sees "company-specific and secular catalysts" driving improving fundamentals and upward revisions to consensus estimates. 5. D.R. Horton (DHI) upgraded to Outperform from Market Perform at Raymond James with the firm saying it is uniquely positioned to capitalize on an unexpectedly tight and historically low existing home inventories, while new home demand remains broadly resilient despite rising prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/27/17
BOFA
06/27/17
NO CHANGE
BOFA
US housing cycle may be inflecting higher, says BofA/Merrill
BofA/Merrill analyst John Lovallo raised single-family house starts and new home sales forecasts for 2018 and 2019 to reflect a continuation in accelerating demand over the past six months. He now expects 2018 single family starts and new homes sales of up 9% year-over-year versus 6% previously, and 2019 growth of up 8% growth year-over-year, versus 5% previously. The analyst believes demand is being supported by the return of first time home buyers, low mortgage rates, and stronger home equity positions. Lovallo raised earnings estimates across the group and reiterated D.R. Horton (DHI) and PulteGroup (PHM) as top picks.
06/30/17
RAJA
06/30/17
UPGRADE
Target $39
RAJA
Outperform
D.R. Horton upgraded to Outperform from Market Perform at Raymond James
Raymond James upgraded D.R. Horton to Outperform and established a $39 price target saying it is uniquely positioned to capitalize on an unexpectedly tight and historically low existing home inventories, while new home demand remains broadly resilient despite rising prices. The analyst believes homebuilders with ample supply of quick delivery homes at affordable price points stand to benefit the most.
07/10/17
WELS
07/10/17
NO CHANGE
WELS
D.R. Horton acquisition positive, says Wells Fargo
Wells Fargo says that D.R. Horton's acquisition of Forestar (FOR) "could ultimately reduce cyclicality and risk, while providing a more visible path to growth." The firm keeps an Outperform rating on D. R. Horton.
OSB Norbord
$37.62

-0.77 (-2.01%)

07/31/17
FBCO
07/31/17
UPGRADE
FBCO
Outperform
Norbord upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Andrew Kuske upgraded Norbord to Outperform from Neutral, citing a "notable tactical window of opportunity." The analyst also raised his price target on the shares to C$50 from C$42.
08/29/17
VERT
08/29/17
DOWNGRADE
VERT
Hold
Norbord downgraded to Hold from Buy at Vertical Research
VMC Vulcan Materials
$117.02

-0.98 (-0.83%)

08/29/17
RHCO
08/29/17
NO CHANGE
RHCO
Vulcan deal positive, should be accretive over longer term, saysSunTrust
SunTrust analyst Rohit Seth says that Vulcan's (VMC) acquisition of Polaris Materials increases Vulcan's exposure to positive catalysts in California and should reduce its competition in the state, potentially enabling its prices to rise. Seth says that Vulcan paid "a large premium" for Polaris, but he thinks that the deal "should be accretive" for Vulcan over the longer term. The analyst keeps a $145 price target and a Buy rating on Vulcan.
05/10/17
RHCO
05/10/17
NO CHANGE
RHCO
Vulcan Materials Q1 EBITDA likely to beat expectations, says SunTrust
SunTrust analyst Rohit Seth expects Vulcan's Q1 EBTIDA to come in at $159M, versus the consensus outlook of $143M. The analyst says that the company may have been hurt by rainy weather in California, but he still expects its Q1 EBITDA to exceed the consensus outlook. He keeps a $141 price target and a Buy rating on the shares.
08/03/17
08/03/17
UPGRADE
Target $145

Overweight
Vulcan Materials upgraded to Overweight at Stephens
As previously reported, Stephens analyst Trey Grooms upgraded Vulcan Materials to Overweight from Equal Weight and raised his price target on the shares to $145 from $140. The analyst views the current risk/reward as much improved with tougher 1H17 comps behind, a 2H17 bar that has now been lowered to a very achievable range, infrastructure demand finally starting to heat up, and a stock that has largely under-performed in recent months.
08/03/17
SPHN
08/03/17
UPGRADE
SPHN
Overweight
Vulcan Materials upgraded to Overweight from Equal Weight at Stephens
CE Celanese
$99.27

0.19 (0.19%)

07/10/17
VERT
07/10/17
DOWNGRADE
Target $103
VERT
Hold
Celanese downgraded to Hold due to valuation at Vertical Research
Vertical Research analyst Kevin McCarthy downgraded Celanese to Hold from Buy citing share outperformance and increased its price target to $103 from $101.
06/20/17
RHCO
06/20/17
NO CHANGE
RHCO
Celanese JV deal positive, says SunTrust
SunTrust analyst James Sheehan says that Celanese's (CE) joint venture with Blackstone (BX) will stabilize the acetate tow market and reduce risk. The analyst says that Celanese could exit the tow business in the medium term ,and he calls the shares' valuation attractive. He keeps a Buy rating on the stock.
06/20/17
RBCM
06/20/17
NO CHANGE
RBCM
Celanese price target raised to $108 from $100 at RBC Capital
RBC Capital analyst Arun Viswanathan raised his price target on Celanese based on the company's intended joint venture with Blackstone (BX). The analyst thinks that the deal "should help reduce uncertainty surrounding the acetate tow business" while "unlocking value through synergies and more efficient use of capital." He adds that the deal "puts Celanese comfortably on pace to meet future earnings targets." The analyst says that the deal marks a positive turning point for Celanese, and he keeps an Outperform rating on the shares.
04/21/17
COWN
04/21/17
NO CHANGE
Target $100
COWN
Outperform
Celanese represents a best long-term chemical idea, says Cowen
Cowen analyst Charles Neivert called Celanese one of his top picks for 2017 and said it represents one of his best long-term chemical ideas. He sees earnings driven by organic growth, inorganic growth, and capacity expansion in key performance products. Neivert reiterated his Outperform rating and raised his price target to $100 from $99 on Celanese shares.
TEN Tenneco
$56.16

0.75 (1.35%)

06/21/17
GUGG
06/21/17
INITIATION
Target $68
GUGG
Buy
Tenneco initiated with a Buy at Guggenheim
Guggenheim analyst Emmanuel Rosner started Tenneco with a Buy rating and $68 price target.
04/03/17
GSCO
04/03/17
INITIATION
Target $71
GSCO
Buy
Tenneco initiated with a Buy at Goldman
Goldman analyst David Tamberrino initiated Tenneco with a Buy and a $71 price target given regulatory driven content growth in Clean Air products as criteria pollutant standards tighten globally, inflecting Commercial Truck and Off-Highway exposure that contributes 33% of EBITDA growth through 2020, its high margin Aftermarket segment, and balance sheet stability.
07/19/17
KEYB
07/19/17
NO CHANGE
KEYB
Tenneco outlook positive, says KeyBanc
KeyBanc analyst Brett Hoselton is upbeat on Tenneco into Q2 results as he thinks that the company's Q2 results will likely beat expectations while full-year estimates for the company could rise. The analyst says that the company has benefited from stronger demand in Europe and improved foreign exchange trends.
GE General Electric
$24.11

0.2 (0.84%)

08/03/17
PIPR
08/03/17
NO CHANGE
Target $14
PIPR
Underweight
3D Systems reported disappointing results, says Piper Jaffray
Piper Jaffray analyst Troy Jensen says 3D Systems (DDD) last night reported disappointing results with weak printer sales being the primary factor in the revenue miss. The weak printer sales are directly correlated with increased competition from HP Inc. (HPQ), General Electric (GE) and others attacking 3D Systems' key product lines, Jensen tells investors in a post-earnings research note. He sees the company's second half of 2017 as "incrementally more challenging" and believes the stock's a "significant premium" to 3D printing peers is unwarranted. The analyst reiterates an Underweight rating on 3D Systems with a $14 price target.
08/31/17
LEHM
08/31/17
INITIATION
Target $41
LEHM
Overweight
Baker Hughes initiated with an Overweight at Barclays
Barclays analyst J. David Anderson started Baker Hughes (BHGE) with an Overweight rating and $41 price target. The analyst believes the merger with GE (GE) goes a long way toward addressing some of the company's legacy issues around execution.
09/07/17
JPMS
09/07/17
NO CHANGE
Target $22
JPMS
Underweight
JPMorgan sees $24 as ceiling not floor for GE shares
In a research note titled "Preparing For The Fall: It's Worse Than We Think.", JPMorgan analyst C. Stephen Tusa says he remains negative on General Electric shares with a $22 price target and Underweight rating. The analyst now views $24 per share as a "ceiling as opposed to a floor prior," and a stock in the high teens as an "investable fair value." GE closed yesterday up 16c to $24.92. Tusa sees downside risk to his well below consensus estimates, and notes the Street is slowly approaching his numbers. GE's cash position is not inflecting, thus current levels are a run rate, not "depressed," Tusa writes. He sees a downside scenario in 2018 GAAP earnings per share to the $1.15-$1.20 range as a potential starting point, compared to current consensus of $1.70.
09/11/17
DBAB
09/11/17
NO CHANGE
Target $21
DBAB
Sell
Deutsche Bank cuts GE price target to $21 on 2018 estimate reduction
Deutsche Bank analyst John Inch cut his price target for General Electric shares to $21 from $24 after reducing his 2018 earnings estimate for the company to $1.55 from $1.85. His forecast now assumes weaker Power, reduced earnings benefit due to curtailed share repurchase, as well as a 5c drag from the adoption of ASU No. 2014-09. There could be further downside risk to estimates after management resets 2018 earnings in November, Inch tells investors in a research note. He notes his estimate does not include the potential adoption of other more conservative accounting practices, including a significantly higher tax rate. The analyst keeps a Sell rating on GE shares.
NX Quanex
$20.25

-0.45 (-2.17%)

10/18/16
KEYB
10/18/16
DOWNGRADE
KEYB
Sector Weight
KeyBanc downgrades three in Building Products space
KeyBanc analyst Kenneth Zener last night downgraded Fortune Brands (FBHS), Ply Gem (PGEM) and Quanex (NX) to Sector Weight from Overweight saying growth is maturing for Building Products. The analyst expects existing homes sales and new starts to slow in 2017, making the sector less attractive. He sees few near-term catalysts for the shares.
08/07/17
SIDC
08/07/17
INITIATION
Target $28
SIDC
Buy
Quanex initiated with a Buy at Sidoti
Sidoti analyst Julio Romero re-initiated Quanex with a Buy and a $28 price target.
07/19/17
WEDB
07/19/17
INITIATION
WEDB
Outperform
Quanex coverage assumed with an Outperform at Wedbush
Wedbush analyst Jay McCanless assumed coverage of Quanex with a $25 price target and an Outperform rating. The analyst predicts that the company's EBITDA will grow about 11% in fiscal 2018, driven by cost cutting and "rising demand for window accessories and cabinets." He expects the company's gross margins to expand in 2H17.
07/19/17
07/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tyson Foods (TSN) reinstated with a Neutral at Credit Suisse. 2. Bob Evans (BOBE) initiated with a Buy at Berenberg. 3. Quanex (NX) coverage assumed with an Outperform at Wedbush. 4. Agile Therapeutics (AGRX) initiated with a Buy at H.C. Wainwright. 5. Caesars (CZR) re-initiated with an Outperform at Imperial Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
EGL Engility
$30.57

-0.03 (-0.10%)

01/31/17
FBRC
01/31/17
NO CHANGE
Target $40
FBRC
Outperform
Engility recent pullback a buying opportunity, says FBR Capital
FBR Capital analyst Christopher Van Horn says he's a buyer of Engility Holdings following the recent pullback in the shares. The Trump administration's focus on military spending will benefit defense firms, while Engility's recent announcement that it is seeking to reprice two term loans could provide incremental accretion to annual cash earnings, Van Horn tells investors in a research note. He continues to believe that Engility provides investors with a "highly compelling story" in the government IT contracting space. The analyst reiterates an Outperform rating on the shares with aw $40 price target.
02/09/17
NBLE
02/09/17
UPGRADE
NBLE
Buy
Engility upgraded to Buy from Hold at Noble Financial
06/13/17
FBRC
06/13/17
NO CHANGE
Target $40
FBRC
Outperform
Engility shares undervalued by investors, says FBR Capital
FBR Capital analyst Christopher Van Horn believes investors are undervaluing the opportunity for Engility to outperform its government IT sector peers over the coming two years. The company's "increased competitive edge" and "solid management team" is not reflected in the share price, Van Horn tells investors in a research note. He believes the stock is overly discounted after dropping 15% this year and reiterates an Outperform rating on Engility with a $40 price target.
03/16/17
VERT
03/16/17
INITIATION
VERT
Hold
Engility initiated with a Hold at Vertical Research
Vertical Research analyst Krishna Sinha started Engility with a Hold rating.
ATKR Atkore
$18.44

0.12 (0.66%)

08/09/17
FBCO
08/09/17
UPGRADE
Target $22
FBCO
Outperform
Atkore upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Julian Mitchell upgraded Atkore to Outperform from Neutral following its sharp share price drop upon the release of Q3 figures. The analyst thinks the concerns that he had highlighted in his initiation report in mid-2016 are now fully factored in. Mitchell also lowered his price target on the shares to $22 from $26 due to his lowered forecasts, reflecting a weaker non-res demand outlook and increased raw material headwinds.
08/09/17
WELS
08/09/17
NO CHANGE
WELS
Atkore weakness overdone, says Wells Fargo
Wells Fargo says that the 22% plunge in Atkore's stock was overdone. The firm thinks the decline prices in further downturns in the company's fiscal 2018 earnings outlook relative to its sector. It believes that the stock now "more than" prices in all upcoming risks, and it expects the shares to increase "modestly" in the nearer term. Wells keeps an Outperform rating on the shares.
CSRA CSRA
$32.32

-0.24 (-0.74%)

07/11/17
RBCM
07/11/17
NO CHANGE
RBCM
Defense stocks still poised for beat and raise results, says RBC Capital
RBC Capital analyst Matthew McConnell says that defense stocks remain poised for beat and raise results for an extended period, given geopolitical tensions in many parts of the world. He believes that the companies most likely to raise their 2017 in conjunction with their Q2 results are General Dynamics (GD), L3 Technologies (LLL), Raytheon (RTN), and Northrop Grumman (NOC). He recommends Raytheon, General Dynamics, Northrop Grumman, CSRA (CSRA), and KEYW (KEYW).
03/16/17
VERT
03/16/17
INITIATION
VERT
Hold
CSRA initiated with a Hold at Vertical Research
Vertical Research analyst Krishna Sinha started CSRA with a Hold rating.
04/04/17
EVER
04/04/17
INITIATION
Target $34
EVER
Outperform
CSRA initiated with an Outperform at Evercore ISI
Evercore ISI analyst Rayna Kumar initiated CSRA with an Overweight and a $34 price target citing industry leading EBITDA margins driven by exposure to high margin, fixed price contracts, a next generation IT focus, and financial discipline.
04/05/17
04/05/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Burlington Stores (BURL) initiated with an Outperform at William Blair. 2. Booz Allen (BAH) was initiated with an In Line while CSRA (CSRA) was initiated with an Outperform at Evercore ISI. 3. Guidance Software (GUID) initiated with an Overweight at Piper Jaffray. 4. Acacia Communications (ACIA) initiated with a Neutral at B. Riley. 5. Keysight Technologies (KEYS) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
SITE SiteOne Landscape
$52.45

0.25 (0.48%)

08/10/17
BARD
08/10/17
NO CHANGE
Target $58
BARD
Outperform
SiteOne Landscape remains a top idea, says Baird
Baird analyst David Manthey noted SiteOne Landscape reported strong Q2 earnings and maintained guidance with increasing confidence. He said organic growth accelerated and margins continued to expand while acquisitions continued to augment growth. He rates SiteOne as a top idea and believes this is the start of a long period of value creation. Manthey reiterated his Outperform rating and raised his price target to $58 from $56 on SiteOne Landscape shares.
05/08/17
JRCO
05/08/17
INITIATION
JRCO
Accumulate
SiteOne Landscape initiated with an Accumulate at Johnson Rice
03/16/17
RBCM
03/16/17
NO CHANGE
RBCM
SiteOne Landscape shares should be bought on strength, says RBC Capital
RBC Capital analyst Robert Wetenhall says that SiteOne reported "solid" Q4 results and provided "favorable" guidance. He noted that the midpoint of the company's fiscal 2017 adjusted EBITDA guidance beat expectations, while it expects its adjusted EBITDA margin to rise significantly. He raised his price target on the shares to $49 from $36 and keeps an Outperform rating on the stock.
03/16/17
BARD
03/16/17
NO CHANGE
Target $50
BARD
Outperform
SiteOne Landscape price target raised to $50 from $44 at Baird
Baird analyst David Manthey raised his price target on SiteOne Landscape to $50 from $44 following solid Q4 results. The analyst believes the company is at the beginning of a period of value creation underpinned by recurring revenues, share gains, M&A, and margin expansion. Manthey said SiteOne Landscape remains his top idea and reiterated his Outperform rating on the shares.
HDS HD Supply
$33.54

-0.21 (-0.62%)

09/08/17
FBCO
09/08/17
DOWNGRADE
Target $33
FBCO
Neutral
HD Supply downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Andrew Buscaglia resumed coverage of HD Supply (HDS) with a Neutral rating, down from a prior Outperform, stating that his opinion on the company's Facilities Maintenance business has soured. The unit is "starting to resemble" Grainger (GWW), said Buscaglia, who added that competition in the space is intensifying and he sees risk to HD Supply's FY17 guidance. Buscaglia has a $33 price target on HD Supply shares.
08/16/17
08/16/17
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL), GoDaddy (GDDY), Wix.com (WIX), Alibaba (BABA), Amazon.com (AMZN), and Priceline (PCLN) were initiated with a Buy at SunTrust, while Snap (SNAP) was initiated with a Sell, and Twitter (TWTR) and eBay (EBAY) were initiated with a Hold. 2. HD Supply (HDS) reinstated with a Neutral at Goldman Sachs. 3. Shiloh Industries (SHLO) initiated with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/05/17
09/05/17
NO CHANGE

RBC Capital identifies companies that could see positive catalysts from Harvey
RBC Capital analyst Deane Dray identifies Grainger (GWW), Wesco (WCC), Xylem (XYL), and HD Supply (HDS) as companies that could benefit from Hurricane Harvey. The analyst says that Grainger " tends to be heavily involved in the cleanup and rebuilding process," and saw a one percentage point daily sales lift from Hurricane Sandy. The analyst thinks that Wesco's sales could be boosted by 0.5 percentage points as utility customers and first responders buy more of its products. She says that "Xylem's dewatering pumps business is expected to play a major role in the recovery/reconstruction efforts in flooded areas." Dray reports that the business accounts for more than 15% of the company's sales. The analyst estimates that about 11% of Hd Supply's revenue is derived from Texas.
08/16/17
GSCO
08/16/17
INITIATION
Target $35
GSCO
Neutral
HD Supply reinstated with a Neutral at Goldman Sachs
Goldman analyst Joe Ritchie reinstated with a Neutral and a $35 price target given uncertainty on how long it will take to to reacquire customers during the supply chain transition.
ROP Roper Technologies
$235.58

-1.79 (-0.75%)

03/24/17
JPMS
03/24/17
DOWNGRADE
Target $219
JPMS
Neutral
Roper Technologies downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst C. Stephen Tusa downgraded Roper Technologies to Neutral saying the recent share rally appropriately reflects benefits from the Deltek deal and the U.S. election. The analyst keeps a $219 price target for the shares.
03/24/17
03/24/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Buy from Strong Buy at Needham with analyst Laura Martin saying the stock's rally moved it to within 6% of her prior price target of $150. The analyst, who raised her FY18 estimates and increased her price target to $165, said the stock is still her top pick, citing Apple's recurring revenue, ability to "dominate" the wealthiest part of the world's population and the stock's still-inexpensive valuation. 2. GameStop (GME) downgraded to Neutral from Buy at BofA/Merrill with analyst Curtis Nagle citing gaming weakness and low visibility. 3. Tesoro (TSO) downgraded to Neutral from Outperform at Credit Suisse with analyst Edward Westlake saying his longer term view of refining margins remains relatively muted, and business has a more negative grey sky sensitivity than some peers given higher California operational costs and a greater share of R&M income, notwithstanding management's progress on diversification and retail integration. The analyst also lowered his price target on the shares to $93 from $110. 4. Entergy (ETR) downgraded to Neutral from Buy at Goldman with analyst Michael Lapides citing a "lower expected value" for Entergy's non-regulated segment, a "lower 12-month SOTP target price," and "few catalysts" for the stock. 5. Roper Technologies (ROP) downgraded to Neutral from Overweight at JPMorgan with analyst C. Stephen Tusa saying the recent share rally appropriately reflects benefits from the Deltek deal and the U.S. election. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/05/17
RAJA
07/05/17
NO CHANGE
Target $268
RAJA
Strong Buy
Roper Technologies has more upside, price target to $268 at Raymond James
Raymond James analyst Brian Gesuale believes Roper Technologies has further upside given diverse end market exposure in mostly non-cyclical markets combined with its growing base of software profits. The analyst reiterates his Strong Buy rating and raised Roper's price target to $268 from $253 given open-ended growth and upside to earnings estimates over the next 24 months.
08/01/17
OPCO
08/01/17
NO CHANGE
Target $257
OPCO
Outperform
Roper Technologies price target raised to $257 from $250 at Oppenheimer
Oppenheimer analyst Christopher Glynn raised his price target for Roper Technologies to $257 from $250 after the company tweaked guidance upward. The analyst reiterates an Outperform rating on the shares.
GGG Graco
$117.24

0.01 (0.01%)

07/31/17
WOLF
07/31/17
UPGRADE
WOLF
Peer Perform
Graco upgraded to Peer Perform from Underperform at Wolfe Research
07/11/17
WOLF
07/11/17
INITIATION
Target $100
WOLF
Underperform
Graco initiated with an Underperform at Wolfe Research
Wolfe Research initiated Graco with an Underperform and a $100 price target.
02/01/17
WDLK
02/01/17
DOWNGRADE
Target $90
WDLK
Hold
Graco downgraded to Hold from Buy at Wunderlich
Wunderlich analyst Liam Burke downgraded Graco to Hold citing valuation following the company's "strong" results. The analyst has a $90 price target for the shares.

TODAY'S FREE FLY STORIES

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MNOV

MediciNova

$6.18

0.3 (5.10%)

17:30
09/22/17
09/22
17:30
09/22/17
17:30
Syndicate
Breaking Syndicate news story on MediciNova »

MediciNova files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ISRG

Intuitive Surgical

$1,031.52

1.31 (0.13%)

17:25
09/22/17
09/22
17:25
09/22/17
17:25
Conference/Events
Intuitive Surgical to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

GD

General Dynamics

$205.41

-0.31 (-0.15%)

17:21
09/22/17
09/22
17:21
09/22/17
17:21
Hot Stocks
General Dynamics Electric Boat awarded $341.2M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$12.85

0.3 (2.39%)

17:19
09/22/17
09/22
17:19
09/22/17
17:19
Syndicate
Breaking Syndicate news story on Coherus Biosciences »

Coherus Biosciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FIBK

First Interstate

$36.90

0.3 (0.82%)

17:18
09/22/17
09/22
17:18
09/22/17
17:18
Syndicate
First Interstate files to sell $250M of Class A common stock »

The shelf registration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

, NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

17:08
09/22/17
09/22
17:08
09/22/17
17:08
Hot Stocks
National Research launches metric to measure healthcare consumer loyalty »

NRC Health launched the…

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$51.79

-0.16 (-0.31%)

, HON

Honeywell

$141.75

0.89 (0.63%)

16:58
09/22/17
09/22
16:58
09/22/17
16:58
Hot Stocks
Chemours files appeal concerning SNAP 20 rule to regulate HFCs »

The Chemours Company (CC)…

CC

Chemours

$51.79

-0.16 (-0.31%)

HON

Honeywell

$141.75

0.89 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.